Walley; Keith R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Walley; Keith R..The latest application filed is for "methods and uses for proprotein convertase subtilisin kexin 9 (pcsk9) inhibitors".

Company Profile

0.1.15

Walley; Keith R. - North Vancouver CA
Walley; Keith R. - Vancouver CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods and Uses for Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors App 20150140005 - Walley; Keith R. ; et al.	2015-05-21
Protein C Rs2069915 As A Response Predictor To Survival And Administration Of Activated Protein C Or Protein C-like Compound App 20110171200 - Walley; Keith R. ; et al.	2011-07-14
Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects App 20110110930 - Walley; Keith R. ; et al.	2011-05-12
Plasminogen Activator Inhibitor-1 (pai-1) Haplotypes Useful As Indicators Of Patient Outcome App 20110104683 - RUSSELL; JAMES A. ; et al.	2011-05-05
Protein C Pathway Associated Polymorphisms As Response Predictors To Activated Protein C Or Protein C-like Compound Administration App 20110027184 - Russell; James A. ; et al.	2011-02-03
Protein C Polymorphisms Useful As An Indicator Of Patient Outcome App 20110020825 - RUSSELL; JAMES A. ; et al.	2011-01-27
Protein C polymorphisms Grant 7,820,376 - Russell , et al. October 26, 2	2010-10-26
Serpine1 Polymorphisms Are Predictive Of Response To Activated Protein C Administration And Risk Of Death App 20100209413 - Walley; Keith R. ; et al.	2010-08-19
Interferon Gamma Polymorphisms As Indicators Of Subject Outcome In Critically Ill Subjects App 20100041600 - Russel; James A. ; et al.	2010-02-18
Vasopressin Pathway Polymorphisms As Indicators Of Subject Outcome In Critically Ill Subjects App 20090298711 - Russell; James A. ; et al.	2009-12-03
Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients App 20090176206 - Russell; James ; et al.	2009-07-09
Coagulation Factor Iii Polymorphisms Associated With Prediction Of Subject Outcome And Response To Therapy App 20090148458 - Russell; James ; et al.	2009-06-11
Protein C And Endothelial Protein C Receptor Polymorphisms As Indicators Of Subject Outcome App 20080026371 - Russell; James ; et al.	2008-01-31
Thrombomodulin (Thbd) Haplotypes Predict Outcome App 20070281300 - Russell; James ; et al.	2007-12-06
Protein c polymorphisms App 20070128594 - Russell; James A. ; et al.	2007-06-07
Plasminogen activator inhibitor-1 (pai-1) haplotypes useful as indicators of patient outcome App 20060246451 - Russell; James A. ; et al.	2006-11-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.